Effective treatment for Demodex blepharitis includes antibiotics, steroids, and lotilaner ophthalmic solution, which resolves ...

A panelist discusses how treating demodex blepharitis with Lotilaner not only eliminates the anterior blepharitis symptoms ...

An eye surgeon has warned of a 'massive issue' that is on the rise in the UK, as he urged people to increase the temperature ...

Leading eye surgeons tell The i Paper that they have seen a surge in cases of eye disease in the past few years ...

XDEMVY™ (lotilaner ophthalmic solution) 0.25%, is FDA approved in the United States for the treatment of Demodex blepharitis. Tarsus is also developing TP-04 for the potential treatment of Ocular ...

XDEMVYTM (lotilaner ophthalmic solution) 0.25%, is FDA approved in the United States for the treatment of Demodex blepharitis. Tarsus is also developing TP-04 for the potential treatment of Ocular ...

Lotilaner, approved for Demodex blepharitis, is the only approved treatment, demonstrating high efficacy and strong launch metrics, with $113 million in annual revenue. Despite a Q3 sales dip ...

As the first treatment cleared by the FDA for Demodex blepharitis, an eye disease estimated to affect 25 million people in the U.S. alone, Tarsus Pharmaceuticals’ Xdemvy is pitting its might ...

Waking up with some gunk in your eyes is usually nothing to worry about. The scientific name for this crust is rheum, and it forms when oil and other debris collect on your eyelids during sleep.

With those in mind, earlier this week, the company announced a multi-channel consumer marketing push in support of Xdemvy (lotilaner ophthalmic solution) 0.25%, a treatment approved by the Food and ...